We guarantee model behavior for a wide range of validated models. Our imaging staff collaborates closely with our clients to guide all aspects of study design, including tracer selection, model, and imaging time points.
A wealth of experience in pharmacology, disease models, and imaging allows us to provide superior quality and timeliness using the most relevant imaging technologies. Our portfolio includes:
- Magnetic Resonance Imaging (MRI)
- Micro-Positron Emission Tomography (microPET)
- 2D Bioluminescence and Fluorescence
- Micro-Computed Tomography (microCT)
- Fluorescence Molecular Tomography (FMT)
- Mouse Dual Energy X-Ray Absorptiometry (DEXA)
- 2D X-Ray Radiography
We have a large and expanding library of high-throughput, quality-controlled, efficient, and validated imaging protocols that have been applied to each of our portfolio technologies. In addition, we apply imaging to an inventory of industry-relevant animal models. The integration of our technologies in a contiguous, ultraclean environment facilitates decision making and allows the application of multi-modality imaging for more powerful datasets.



